Search - tctmd.com

Displaying 1 - 20 of 179

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

Todd Neale

December 04, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Presentation TCT 2023

My Worst DVT of the Year

Presenter: Ari Mintz

October 26, 2023

Presentation TCT 2023

My Best DVT Case of the Year

Presenter: Matthew Finn

October 26, 2023

Presentation TCT 2023

My Worst PE Case of the Year

Presenter: Asma Khaliq

October 26, 2023

Presentation TCT 2023

My Best PE Case of the Year

Presenter: Tai Kobayashi

October 26, 2023

Presentation TCT 2023

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

Presenter: Jonathan Paul

October 25, 2023

Presentation TCT 2023

A Differentiated Approach Delivering Targeted Thrombectomy for VTE – Clot Burden or Hemodynamics? (Akura Medical)

Presenter: Murali Srivathsa

October 23, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

Hormonal Birth Control, NSAID Use Together Linked to VTE

Caitlin E. Cox

September 11, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

Presentation Fellows 2023

FLAME and clinical implications for high risk PE

Presenter: Jay Giri

May 12, 2023

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

November 2024 Dispatch for the CV Team

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

My Worst DVT of the Year

My Best DVT Case of the Year

My Worst PE Case of the Year

My Best PE Case of the Year

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

A Differentiated Approach Delivering Targeted Thrombectomy for VTE – Clot Burden or Hemodynamics? (Akura Medical)

TCTMD’s Top 10 Most Popular Stories for September 2023

Hormonal Birth Control, NSAID Use Together Linked to VTE

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

FLAME and clinical implications for high risk PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content